CivaSheet (NCT03290534)

Name: CivaSheet trial for Lung Cancer (NCT03290534)
Uploaded: 2026-10-31T21:18:43.289Z
Duration: 1 min 14 s
Description: CivaSheet trial for Lung Cancer (NCT03290534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03290534.

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®: a one-minute explainerNCT032905341 min

CivaSheet trial for Lung Cancer (NCT03290534). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adults with suspected or confirmed stage I or II non-small-cell lung cancer in an upper lung lobe. The mass must be no larger than seven centimeters on CT.

The idea: permanently implant CivaSheet near the surgical margin to deliver local radiation. Its palladium-103 sources and gold shielding direct radiation toward diseased tissue while aiming to limit exposure of nearby structures. Researchers assess one-year local cancer control.

This phase 2 study plans 40 patients. CivaTech Oncology sponsors it. NYU Langone Health in New York is the sole recruiting US site.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.